Kolexia
Petit-Bourgeois Emmanuelle Hématologie
Petit-Bourgeois Emmanuelle
Hématologie
Hôpital Saint Vincent de Paul Lille
Lille, France
47 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Myélome multiple Tuberculose latente Tuberculose Lymphomes Tuberculose pulmonaire Thalassémie Maladie aigüe Lymphome B de la zone marginale Leucémie chronique lymphocytaire à cellules B

Collaborateurs

Voir plus
Pascal Laurent
Pascal Laurent
Faculte De Medecine Et Maïeutique, Lille, France
Hivert Benedicte
Hivert Benedicte
Hôpital Saint Vincent de Paul Lille, Lille, France
Carpentier Benjamin
Carpentier Benjamin
Hôpital Saint Vincent de Paul Lille, Lille, France
Peugniez Charlotte
Peugniez Charlotte
Centre Oscar-Lambret, Lille, France

Industries

Voir plus
A+A
74 collaboration(s)
Dernière en 2023
B3TSI
36 collaboration(s)
Dernière en 2023
Sanofi
4 collaboration(s)
Dernière en 2023
Genactis SAS
4 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05
65th ASH Annual Meeting Abstracts   02 novembre 2023
Combined regulation of pro-inflammatory cytokines production by STAT3 and STAT5 in a model of infection of alveolar macrophages.
Frontiers in immunology   28 septembre 2023
Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies.
Journal of clinical medicine   08 mars 2023
What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort
Annual Meeting Abstracts 2022   15 novembre 2022
Multicenter Open Label Phase 3 Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients (≥ 65; < 80 Years). IFM2020-05/Benefit
Annual Meeting Abstracts 2022   15 novembre 2022
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype
Annual Meeting Abstracts 2022   15 novembre 2022
Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays.
Journal of clinical microbiology   18 avril 2022
Natural T Cell Epitope Containing Methyl Lysines on Mycobacterial Heparin-Binding Hemagglutinin.
Journal of immunology (Baltimore, Md. : 1950)   02 mars 2020
Proportions of interferon-γ-producing ascites lymphocytes in response to mycobacterial antigens: A help for early diagnosis of peritoneal tuberculosis in a low TB incidence country.
PloS one   04 avril 2019
HBHA-Induced Polycytotoxic CD4 T Lymphocytes Are Associated with the Control of Infection in Humans.
Journal of immunology (Baltimore, Md. : 1950)   17 décembre 2018